Next Article in Journal
Minimal Residual Disease Detection in Acute Lymphoblastic Leukemia
Next Article in Special Issue
A Curcumin Derivative Activates TFEB and Protects Against Parkinsonian Neurotoxicity in Vitro
Previous Article in Journal
Regulation of Osteoclast Differentiation at Multiple Stages by Protein Kinase D Family Kinases
Previous Article in Special Issue
Substantiation for the Use of Curcumin during the Development of Neurodegeneration after Brain Ischemia
Open AccessReview

Mutual Two-Way Interactions of Curcumin and Gut Microbiota

Laboratory of Ischemic and Neurodegenerative Brain Research, Mossakowski Medical Research Centre, Polish Academy of Sciences, 02-106 Warsaw, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(3), 1055; https://doi.org/10.3390/ijms21031055
Received: 19 January 2020 / Revised: 29 January 2020 / Accepted: 3 February 2020 / Published: 5 February 2020
(This article belongs to the Special Issue Curcumin in Health and Disease: New Knowledge)
Curcumin, an herbal naturally occurring polyphenol, has recently been proposed for the treatment of neurodegenerative, neurological and cancer diseases due to its pleiotropic effect. Recent studies indicated that dysbiosis is associated with the abovementioned and other diseases, and gut microflora may be a new potential therapeutic target. The new working hypothesis that could explain the curative role of curcumin, despite its limited availability, is that curcumin acts indirectly on the brain, affecting the “gut–brain–microflora axis”, a complex two-way system in which the gut microbiome and its composition, are factors that preserve and determine brain health. It is therefore suspected that curcumin and its metabolites have a direct regulatory effect on gut microflora and vice versa, which may explain the paradox between curcumin’s poor bioavailability and its commonly reported therapeutic effects. Curcumin and its metabolites can have health benefits by eliminating intestinal microflora dysbiosis. In addition, curcumin undergoes enzymatic modifications by bacteria, forming pharmacologically more active metabolites than their parent, curcumin. In this review, we summarize a number of studies that highlight the interaction between curcumin and gut microbiota and vice versa, and we consider the possibility of microbiome-targeted therapies using curcumin, particularly in disease entities currently without causal treatment. View Full-Text
Keywords: curcumin; gut microbiota; dysbiosis; gut–brain–microbiota axis; herbal medicine; curcumin metabolites; pro-health bacteria; intestinal health curcumin; gut microbiota; dysbiosis; gut–brain–microbiota axis; herbal medicine; curcumin metabolites; pro-health bacteria; intestinal health
Show Figures

Figure 1

MDPI and ACS Style

Pluta, R.; Januszewski, S.; Ułamek-Kozioł, M. Mutual Two-Way Interactions of Curcumin and Gut Microbiota. Int. J. Mol. Sci. 2020, 21, 1055.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop